The popularity of GLP-1 agonists should also be investigated in terms of their potential to slow the progression of obesity-mediated cancers
Hypoglycemia is an important consideration for anyone taking diabetes medications
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
With the designation lifted, that regulatory window has effectively closed
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1alpha), in patients with refractory solid tumors
Most of these compounds still lack robust clinical data proving their safety and long-term efficacy, says Dr